{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:57:41Z","timestamp":1767211061863,"version":"3.37.3"},"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0212801","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T19:12:24Z","timestamp":1551294744000},"page":"e0212801","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma"],"prefix":"10.1371","volume":"14","author":[{"given":"Claire","family":"Franczak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovic","family":"Dubouis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Gilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Husson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Rouyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Demange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Merlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9548-6522","authenticated-orcid":true,"given":"Alexandre","family":"Harl\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"unstructured":"International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. Accessed 8 June 2018.","key":"ref1"},{"issue":"9927","key":"ref2","first-page":"1490","article-title":"Colorectal cancer","volume":"383","author":"H Brenner","year":"2014"},{"key":"ref3","first-page":"887","article-title":"Diagnostic accuracy of computed tomography for colon cancer staging: a systematic review","volume":"46","author":"AM Leufkens","year":"2011"},{"key":"ref4","first-page":"1386","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"E Van Cutsem","year":"2016"},{"issue":"10","key":"ref5","first-page":"1626","article-title":"Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer","volume":"26","author":"RG Amado","year":"2008"},{"issue":"8","key":"ref6","first-page":"3992","article-title":"KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer","volume":"66","author":"A Lievre","year":"2006"},{"issue":"6","key":"ref7","first-page":"594","article-title":"KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer","volume":"12","author":"W De Roock","year":"2011"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"e0153576","DOI":"10.1371\/journal.pone.0153576","article-title":"Detection of BRAF mutation using a Fully Automated Platform and Comparison with HighResolution Melting, Real-Time Allele Specific Amplification, Immunohistochemistry and NextGeneration Sequencing Assays, for patients with Metastatic Melanoma","volume":"11","author":"A Harl\u00e9","year":"2016","journal-title":"PlosOne"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","article-title":"Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer","volume":"369","author":"JY Douillard","year":"2013","journal-title":"N Engl J Med"},{"issue":"10","key":"ref10","first-page":"1450","article-title":"Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study","volume":"117","author":"E Shinozaki","year":"2017"},{"issue":"3","key":"ref11","first-page":"363","article-title":"Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation Sequencing","volume":"11","author":"A Harl\u00e9","year":"2016"},{"key":"ref12","first-page":"26732","article-title":"The minimal amount of starting DNA for Agilent\u2019s hybrid capture-based targeted massively parallel sequencing","volume":"6","author":"J Chung","year":"2016"},{"issue":"3","key":"ref13","first-page":"314","article-title":"Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study","volume":"26","author":"P Marino","year":"2018"},{"issue":"9","key":"ref14","first-page":"757","article-title":"A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day","volume":"71","author":"A Uguen","year":"2018"},{"key":"ref15","first-page":"139","article-title":"Clinical performance evaluation of a sensitive, rapid low-throughput test for <italic>KRAS<\/italic> mutation analysis using formalin-fixed, paraffin-embedded tissue samples","volume":"17","author":"C Weyn","year":"2017"},{"issue":"26","key":"ref16","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"PB Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1136\/jclinpath-2018-205197","article-title":"Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm","author":"C De Luca","year":"2018"},{"issue":"4","key":"ref18","first-page":"295","article-title":"EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay","volume":"70","author":"C De Luca","year":"2017"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0212801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:52:14Z","timestamp":1589010734000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0212801"}},"subtitle":[],"editor":[{"given":"Giancarlo","family":"Troncone","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0212801","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,2,27]]}}}